Putting your money where your mouth is, Curium to acquire Lantheus in deal valued at up to $8 billion Curium, a radiopharmaceutical company controlled by private equity firm CapVest Partners, has entered into a definitive agreement to acquire all outstanding shares of...
This has been a rough week for the Biotech Market, Novo Nordisk’s fails to reduce heart risk in ZEUS trial Novo Nordisk (NYSE: NVO) announced that its experimental drug ziltivekimab did not reduce the risk of major adverse cardiovascular events (MACE) in a phase 3...
A good payoff, Etsy sells Depop to eBay for approximately $1.4 billion Etsy, Inc. (ETSY) announced it has completed the sale of Depop, a fashion resale marketplace, to eBay Inc. (Nasdaq: EBAY) for approximately $1.4 billion in cash.The total consideration reflects a...
You have a good memory, Nocera acquires 30% stake in Taiwan memory distributor QMAX Nocera, Inc. (NCRA) has acquired a 30% controlling interest in QMAX Technology Co., Ltd., a Taiwan-based authorized distributor of Micron and Crucial memory and storage products,...
That’s a huge fall, Capricor Therapeutics stock Falls 26% Following FDA Briefing Capricor Therapeutics (NASDAQ:CAPR) shares fell 40% Monday after the FDA posted briefing documents ahead of the company’s July 29 advisory committee meeting.The Cellular, Tissue,...
Seeking approval, MannKind stock jumps on FDA approval MannKind Corporation (NASDAQ: MNKD) shares rose 6% Friday morning after the company announced FDA approval of Furoscix ReadyFlow and a $50 million private placement.The FDA approved Furoscix ReadyFlow (furosemide...
